← Back to home

Non-small cell lung cancer (NSCLC) with nonprogression following 4 cycles of platinum-based chemotherapy

Clinical trials for Non-small cell lung cancer (NSCLC) with nonprogression following 4 cycles of platinum-based chemotherapy explained in plain language.

Never miss a new study

Get alerted when new Non-small cell lung cancer (NSCLC) with nonprogression following 4 cycles of platinum-based chemotherapy trials appear

Sign up with your email to follow new studies for Non-small cell lung cancer (NSCLC) with nonprogression following 4 cycles of platinum-based chemotherapy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New drug combo aims to keep lung cancer in check after chemo

Disease control Completed

This Phase 2 trial tested whether adding OSI-906 to erlotinib (Tarceva) as maintenance therapy could help people with advanced non-small cell lung cancer (NSCLC) who had not progressed after initial chemotherapy. The study enrolled 205 participants and compared the combination ag…

Matched conditions: NON-SMALL CELL LUNG CANCER (NSCLC) WITH NONPROGRESSION FOLLOWING 4 CYCLES OF PLATINUM-BASED CHEMOTHERAPY

Phase 2 • Sponsor: Astellas Pharma Inc • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC

Non-small cell lung cancer (NSCLC) with nonprogression following 4 cycles of platinum-based chemotherapy

Get alerted when new Non-small cell lung cancer (NSCLC) with nonprogression following 4 cycles of platinum-based chemotherapy trials appear

New drug combo aims to keep lung cancer in check after chemo